Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
about
Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in ratsSRC-3 has a role in cancer other than as a nuclear receptor coactivator.Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complexInhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells.Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells.Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) familySteroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferationPhosphorylation of AIB1 at mitosis is regulated by CDK1/CYCLIN B.The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial contentRole of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription.Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis.Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.Role of the nuclear receptor coactivator AIB1/SRC-3 in angiogenesis and wound healing.Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer.The role of AIB1 in breast cancerHER2/NEU GENE EXPRESSION PRODUCTS EVALUATED WITH SUPERPARAMAGNETIC, GENETICALLY ENGINEERED ANTIBODIESThe nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expressionHER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancerTyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cellsBufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1SRC-3 Plays a Critical Role in Human Umbilical Vein Endothelial Cells by Regulating the PI3K/Akt/mTOR Pathway in Preeclampsia.Inhibitory effects of fucoxanthinol on the viability of human breast cancer cell lines MCF-7 and MDA-MB-231 are correlated with modulation of the NF-kappaB pathway.The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.Transcriptional repression of the tumor suppressor DRO1 by AIB1.Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor.The effects of bufadienolides on HER2 overexpressing breast cancer cells.
P2860
Q24657393-B7292333-1D68-4241-8800-459888F328DDQ27687681-EB0AFA61-C194-4FC4-B8E1-16D009F1DF26Q33701396-288528E7-7FE2-44AD-9467-579F5886E3D0Q33948775-A3E2863C-93E0-47A8-B14D-389E4AB3773AQ33954542-C3F47611-0B61-4809-87B1-28461CD308E3Q34013708-8422D940-53FE-4408-840B-4893CBDE7A4FQ34069119-84D36FF2-48F3-4BEB-A0DF-615E2E824BDFQ34098262-AD220DFC-C556-470B-BA26-4A7A96BDEBADQ34286419-39610E47-9D63-46B9-B8E3-24857C93E50AQ34458338-8C69C9AB-76CC-45B8-A716-71D6D6040345Q34712100-3595F903-9427-41D2-9AC5-F0F55651135FQ35128269-16EFDC23-3868-4157-8E5A-6F8B50887320Q35558470-96442C35-2BF4-431C-93EB-C339710ECEEAQ35595711-CD12C61C-35F8-4DB4-99E2-19BF936C0156Q35768232-F6DEDAC3-BA59-4640-BA71-9E098FFCC402Q35952104-F3D6DDDD-F0B0-4E0A-9AC7-533593BA66CAQ35987349-18ED02B8-619E-473F-90FD-79B3D8D0BDABQ36423878-DDEF117D-3951-4754-97A1-07709F2BE462Q36505059-868CFDF5-9064-473D-A4C3-054D8974A0EBQ36811130-58C3932F-44CD-4D0D-B3AD-44983A512A36Q36898979-F8C125B0-F3C0-4E93-A440-6A373D5EAE26Q36903047-E1CFFCA8-AAF3-4E1E-BD1B-BE394C1BCC27Q36949747-A77C9148-1752-4883-B2F4-51DF55310BC3Q36998051-97761B05-84BA-48BE-9718-A62D4929FB3AQ37626561-2BAC087E-7DCF-464E-BF14-7E4A48764DBAQ38615970-F53ACADA-57CB-4B46-8D2E-BC73E2CDF89BQ39001596-3293F47A-EA20-42F0-8008-45337560B5B6Q39243814-C24237BF-6C21-4844-A356-7BC654637D44Q39483576-16E39F0D-C4BE-44A7-8214-8D8325FEC2ACQ39998587-7D9632FB-6A3A-4DEF-9680-2A5E9BE991FCQ53805460-CA5CBF83-A63A-4411-B922-2272635AB78C
P2860
Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Epidermal growth factor recept ...... amplified in breast cancer 1.
@en
type
label
Epidermal growth factor recept ...... amplified in breast cancer 1.
@en
prefLabel
Epidermal growth factor recept ...... amplified in breast cancer 1.
@en
P2093
P2860
P1433
P1476
Epidermal growth factor recept ...... , amplified in breast cancer 1
@en
P2093
Anna T Riegel
Mark Fereshteh
Tyler Lahusen
P2860
P304
P356
10.1158/0008-5472.CAN-07-1013
P407
P577
2007-08-01T00:00:00Z